
RegulatoryOct 5, 2026, 06:36 AM
IceCure Medical's CPT Code Request Denied; Plans Resubmission in 2027
AI Summary
IceCure Medical Ltd. announced that the American Medical Association's CPT Editorial Panel has decided not to approve a permanent CPT category I code for cryoablation of cancerous breast tumors at this time. The company plans to resubmit the request in June 2027 after gathering more clinical evidence. The existing temporary CPT Category III code remains active, ensuring continued reimbursement from CMS for the ProSense procedure.
Key Highlights
- American Medical Association's CPT Editorial Panel decided against approving a permanent CPT category I code for cryoablation of breast tumors.
- The decision is based on the current stage of clinical evidence and utilization of IceCure's ProSense system.
- The temporary CPT Category III code remains in place, allowing for approximately $4,000 facility fee reimbursement from CMS.
- IceCure plans to resubmit the CPT category I code request in June 2027 after further expanding clinical evidence and utilization.
Price Impact
More from ICCM